Open access
Oct 2026
FAP-targeted [68Ga]BED003-PET compared with [18F]DOPA-PET in patients with recurrent medullary thyroid carcinoma
Molecular imaging of recurrent or advanced medullary thyroid carcinoma (MTC) remains clinically challenging. [ 18 F]DOPA-PET is an established reference standard, but its sensitivity is limited and dependent on tumour burden and biomarker levels. Fibroblast activation protein (FAP)-targeted PET has emerged as a...
D. Ventura, B. Noto, Philipp Backhaus et al.
· Frontiers in Nuclear Medicin... · 0 citations